Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.090
+0.070 (3.47%)
At close: Jun 26, 2026, 4:00 PM EDT
2.120
+0.030 (1.43%)
After-hours: Jun 26, 2026, 5:50 PM EDT
Compugen Employees
Compugen had 75 employees as of December 31, 2025. The number of employees increased by 1 or 1.35% compared to the previous year.
Employees
75
Change (1Y)
1
Growth (1Y)
1.35%
Revenue / Employee
$968,747
Profits / Employee
$464,733
Market Cap
197.68M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| MediWound | 121 |
| Arcturus Therapeutics Holdings | 111 |
| Nkarta | 108 |
| NovaBridge Biosciences | 30 |
| Unicycive Therapeutics | 22 |
| Equillium | 15 |
| NervGen Pharma | 10 |
CGEN News
- 9 days ago - Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress - PRNewsWire
- 12 days ago - Compugen Transcript: Fireside chat - Transcripts
- 16 days ago - Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026 - PRNewsWire
- 19 days ago - Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development - PRNewsWire
- 5 weeks ago - Compugen price target lowered to $5 from $13 at Leerink - TheFly
- 5 weeks ago - Compugen Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 5 weeks ago - Compugen files $400M mixed securities shelf - TheFly
- 5 weeks ago - Compugen Earnings Call Transcript: Q1 2026 - Transcripts